Jane Street’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$575K Sell
47,100
-30,300
-39% -$455K ﹤0.01% 7688
2026
Q2
$1.38M Buy
77,400
+58,700
+314% +$733K ﹤0.01% 5853
2026
Q1
$170K Sell
18,700
-2,400
-11% -$30.3K ﹤0.01% 10289
2025
Q4
$289K Sell
21,100
-18,200
-46% -$337K ﹤0.01% 8919
2025
Q3
$856K Buy
+39,300
New +$463K ﹤0.01% 6660
2021
Q4
– Sell
-45,000
Closed -$799K – 10131
2021
Q3
$799K Buy
+45,000
New +$844K ﹤0.01% 6364

Other funds holding CLPT

Jane Street's CLPT Position: Q3 2026 in Review

Jane Street opened a new position in ClearPoint Neuro (CLPT) in Q3 2026: 82,828 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #6473 among its holdings. This is a return to the name: Jane Street previously reported a position in CLPT as recently as Q4 2025.

Jane Street first reported a position in CLPT in Q3 2021 and has held it in 13 quarters since. The position peaked at $3.42M in Q4 2024. 126 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Jane Street held 82,828 shares of ClearPoint Neuro worth $1.01M as of Q3 2026.
  • ClearPoint Neuro was a new Jane Street position in Q3 2026.
  • ClearPoint Neuro made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #6473 holding.
  • Jane Street first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 13 quarters since.
  • Jane Street's ClearPoint Neuro position peaked at $3.42M in Q4 2024.
  • 126 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.